June 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
June 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
June 2026
The global drug-eluting balloon catheters market size was valued at USD 1.53 billion in 2025 and is expected to hit around USD 4.28 billion by 2035, growing at a CAGR of 10.83%.
June 2026
The global drug repurposing market size is estimated to hit around USD 62.24 billion by 2035, increasing from USD 36.87 billion in 2025, with a CAGR of 5.38%.
June 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
June 2026
The global drug screening market size is exhibited at USD 10.55 billion in 2025 and is anticipated to attain around USD 43.72 billion by 2035 with a CAGR of 15.28%.
June 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 792.67 million in 2025, with a CAGR of 9.00%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
February 2026
The global drug of abuse testing market size was estimated at USD 14.67 billion in 2025 and is projected to hit around USD 24.14 billion by 2035, with a notable CAGR of 5.11%.
January 2026
The global drug device combination products market size is projected to attain around USD 382.67 billion by 2035 from USD 165.26 billion in 2025 with a CAGR of 8.76%.
December 2025
The global drug formulation market size is calculated at USD 1.96 trillion in 2025 and is projected to hit around USD 3.50 trillion by 2035 with a CAGR of 5.97%.
December 2025
The drug delivery devices market size is valued at USD 303.28 billion in 2025 and is expected to hit around USD 533.31 billion by 2035, growing at a CAGR of 5.81% from 2026 to 2035.
July 2026
The global pharmacovigilance and drug safety software market size was evaluated at USD 2.09 billion in 2025 and is predicted to hit around USD 5.06 billion by 2035, growing at a CAGR of 9.24%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
July 2026
The global ophthalmic drug CDMO market expands with advancements in drug delivery systems and rising prevalence of chronic eye diseases globally.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The advanced technologies in marine drug development market accelerates drug discovery with advanced tech and deep-sea pharmaceutical potential.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
July 2026
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
July 2026
The next?gen delivery systems for genetic drug market is expanding with lipid nanoparticles, viral vectors, and extracellular vesicles enabling precision gene delivery.
July 2026
The global AI-powered drug formulation market is growing as pharmaceutical companies leverage AI to optimize drug design, delivery, and efficacy.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global sarcoidosis drug market size was estimated at USD 8.82 billion in 2025 and is expected to hit around USD 15.93 billion by 2035, growing at a CAGR of 6.09%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com